The influence of genetic variability within the major histocompatibility complex (MHC) region on variations in immune responses to childhood vaccination was investigated. The study group consisted of 135 healthy infants who had been immunized with hepatitis B (HBV), 7-valent pneumococcal conjugate (PCV7), and diphtheria, tetanus, acellular pertussis (DTaP) vaccines according to standard childhood immunization schedules. Genotype analysis was performed on genomic DNA using Illumina Goldengate MHC panels (Mapping and Exon Centric). At the 1 year post vaccination check-up total, isotypic, and antigen-specific serum antibody levels were measured using multiplex immunoassays. A number of single nucleotide polymorphisms (SNPs) within MHC Class I and II genes were found to be associated with variations in the vaccine specific antibody responses and serum levels of immunoglobulins (IgG, IgM) and IgG isotypes (IgG1, IgG4) (all at p< 0.001). Linkage disequilibrium patterns and functional annotations showed that significant SNPs were strongly correlated with other functional regulatory SNPs. These SNPs were found to regulate the expression of a group of genes involved in antigen processing and
Introduction
Even with uniform administration schemes, large inter-individual variability exists in vaccine responsiveness among vaccine recipients. For example, 5-20% and 2-10% of healthy individuals experience either hypo-or non-responsiveness to hepatitis B (HBV) or measles vaccination, respectively [1] [2] [3] [4] . A strong genetic component has been demonstrated in the regulation of immune responses to the vaccines. A number of polymorphisms have been reported to be associated with vaccine responsiveness including variants of the major histocompatibility complex (MHC) [5] [6] [7] and cytokine and cytokine receptor genes [8] [9] [10] [11] .
to vaccine responsiveness. In the present study, a focused approach has been taken to examine the association of SNPs within the MHC region with variation in childhood vaccine responses.
Materials and methods

Study population and vaccinations
Study procedures were approved by the Institutional Review Boards of all participating institutions. The subjects were infants seen in two University-affiliated general pediatrics clinics for routine 1 year old checkup examinations. These clinics routinely obtained blood by finger stick during the 1 year checkup to screen for anemia and lead poisoning. If parents gave informed consent, additional tubes of blood for genomic DNA were obtained. In addition, immunization records were reviewed to document history of immunization with HBV (Recombivax ® , Merck&Co., Inc., White-house Station, NJ); DTaP (Daptacel ® , Sanofi Pasteur, Ontario, CA); heptavalent pneumococcal conjugate vaccine (PCV7-serotypes 4, 6B, 9V, 14, 18C, 19F, 23F) (Prevnar ® , Wyeth, Philadelphia, PA); inactivated polio vaccine (IPV); and Haemophilus influenza type b (Hib) conjugate vaccine in accordance with thencurrent guidelines for childhood immunization [27] . A total of 135 healthy infants, aged 11.5-14 months of age (mean: 12.6 months), were recruited into the study. The majority of children were non-Hispanic whites (121) and male (77). The demographics and immunological variables of the participants that were included in the analysis are given in Table 1 .
Genotyping
Genomic DNA was extracted from whole blood samples using the QIAamp blood kit (QIAGEN Inc., Chatsworth, CA). Genotyping was performed according to the standard protocol provided by Illumina using the MHC Panel Set and Golden Gate protocol (Illumina Inc., San Diego, CA). The MHC SNP set consisted of two oligonucleotide pools, MHC Mapping Panel and MHC Exon-Centric Panel for 1228 and 1293 SNP loci, respectively. Both panels cover 2360 independent loci spaced at an average of 2.08 kb (range: 0.005-71.05 kb). Genotyping was performed in a 16-well format using universal BeadChips. A total of 250 ng to 1 µg DNA was used for each assay depending on the source. Genotypes were auto called using GenomeStudio software (Illumina, Inc., San Diego, CA).
Microsphere coupling
Pneumococcal polysaccharides (PnPS) were obtained from ATCC, Manassas, VA. Pneumococcal cell wall polysaccharide (CPS) was obtained from Staten Serum Institute (Copenhagen, Denmark). Diphtheria and tetanus toxoids were obtained from University of Massachusetts Biologics Laboratories, Jamaica Plain, MA. The PnPSs were conjugated to spectrally distinguishable microspheres (Luminex, Austin, TX) using 4-(4,6-dimethoxy [1, 3, 5] triazin-2-yl)-4-methyl-morpholinium [28] . Diphtheria and tetanus toxoids were conjugated to spectrally distinguishable microspheres using 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride and sulfo-N-hydroxysuccinimide [28] .
Serum collection and analyses
Blood samples were collected at approximately 1 year of age (mean: 12.6 months). Serum was isolated and stored at −20 °C until analysis. Vaccine-specific antibody responses to PnPSs, diphtheria and tetanus toxoids; and total serum immunoglobulin levels (IgM, IgA, IgG and IgG subclasses) were measured by multiplex assay as previously described [29, 30] . Briefly, microspheres coupled to PnPSs, diphtheria and tetanus toxoids were mixed and added to standards and samples diluted in PBS containing 1%BSA, 0.05%Tween 20, 10 µg/ml of CPS, and 100 µg/ml of PnPS 22. Measurement and data analysis were performed using the Bioplex multiplex testing platform (BioRad, Hercules, CA). Assays were performed in duplicate. Serum concentrations of IgG, IgA, IgM, and IgG subclasses were measured in duplicate using Beadlyte ® assay according to the manufacturer's instructions (Upstate, Lake Placid, NY).
Levels of specific serum antibody to HBsAg were determined using a commerciallyavailable enzyme immunoassay according to the manufacturer's instructions (ETI-AB-AUK PLUS, DiaSorin Inc., Stillwater, MN). All serum measurements were above the minimum detection limit of the assay.
Statistical analyses
SNP-specific deviations from the Hardy-Weinberg Equilibrium were tested using chisquared goodness-of-fit tests. Antibody levels were transformed to their log values (base 2) before analysis to fit the normality assumptions. These variables were included in the analysis first as continuous variables then they were turned into binary variables at thresholds of 10% and 15% to examine the trend in data.
The genotype confidence score of the assay was set to 0.25 in GenomeStudio Genotyping module. Alleles that were not called in a sample were coded as missing in the analysis. For missing rates per individual and per SNP, a threshold of 2% was used. Datasets from exoncentric and mapping panels were merged using PLINK [31] . This dataset contained 1856 SNPs for 135 subjects including 77 males and 58 females. The initial two datasets had 111 markers in common and the concordance rate of these markers was 0.999. Initial datasets had 124 subjects in common thus, 11 subjects had set of markers either from exon-centric or mapping panels. The total genotype rate for the merged dataset was 0.96. Replicate sample comparisons within and across DNA genotyping plates also demonstrated high agreement (data not shown).
Statistical analysis was performed using PLINK version 1.07 [31] . Linear and logistic regression models, with adjustments for gender, age and ethnicity, were used to test for differences between antibody levels (as continuous and binary data) according to genotypes. Associations were tested individually and based on principal components determined from combinations of antibody levels. Linkage disequilibrium (LD) and haplotype blocks were assessed using default parameters in Haploview [32] . Pairwise LD was calculated only for SNPs within 200 kb. SNAP was used to find proxy SNPs within 500 kb based on LD and physical distance [33] . RegulomeDB was used to annotate SNPs with known and predicted regulatory elements [34] .
Results
All analyses were conducted on both the quantitative antibody phenotype and the dichotomized serotype status (lowest 10% and 15%). Since discretization could result in arbitrary cut-off levels, the focus of this report will be on the results with the quantitative phenotypes. However, the results for both analyses were consistent with each other (overlaps with the binary analysis are marked in Tables 2 and 3) .
Association between vaccine specific antibody responses and SNPs
1856 SNPs in 154 genes were studied for their influence on vaccine induced serum antibody levels. All genotype frequencies were in Hardy Weinberg Equilibrium. After adjusting for gender, age and ethnicity, several SNPs were significantly associated with vaccine specific antibody responses. Table 2 summarizes these associations and provides p values calculated in an additive manner. The RPP21 (rs3129820 and rs6936217), ZBTB12 (rs558702), BF (rs1270942), STK19 (rs389884), TNXB (rs1150758, 1150753), CREBL1 (rs1269852), NOTCH4 (rs3134942 and rs3131296), BTNL2 (rs3129950), HLA-DRA (rs984778, rs3135338, rs3135395 and rs2395178) and HLA-DQA1 (rs2187668) SNPs were significantly associated with variations in median anti-HBsAg antibody levels (p< 0.001). In addition, the GG genotype of the PSORS1C1 rs3130454 SNP was associated with a lower serum antibody levels to tetanus (p< 0.001). Regarding antibody response to PCV7, the HLA-DOB (rs2857130, rs2857127, rs6929716, rs7383433, rs5009557) and TAP2 (rs1015166) SNPs were associated with significant variations in PnPS4 (p< 0.001) serotype specific antibody titers. The HLA-DOB rs5009557 SNP was also associated with variation in PnPS9V serotype level. The GG genotype of LEMD2 rs755495 SNP was associated with higher serum antibody levels to serotype PnPS14 (p<0.001). SNPs in the COL11A2 (rs9368758, rs2269346), HSD17B8 (rs383711), RING1 (rs213210) were associated with variations in PnPS19F serotype-specific antibody titers (p < 0.001) while the NOTCH4 SNPs (rs2071280, rs2071287, rs2071277) were associated with altered response to PnPS23F serotype. Manhattan plots showing the association signals for each vaccine (and serotype) are provided in Supplementary Fig. 1 . None of the other polymorphisms that were examined showed any significant association with immune responses to vaccine antigens.
Supplementary material related to this article can be found, in the online version, at http:// dx.doi.org/10.1016/j.vaccine.2013.09.026.
Association between immunoglobulin levels and SNPs
Significant associations (p < 0.001) were observed between certain SNPs and serum concentrations of IgM, IgG, and IgG subclasses (Table 3) . Total IgG and IgG1 subclass levels significantly effected in subjects with HLA-F and FLJ35429 SNPs while IgG4 levels varied significantly by the BTNL2 and C6orf10 SNPs (<0.001). The HLA-G, HLA-C, HLA-DRA, HCG9, FLJ35429, MAS1L, OR2W1, OR2J3, OR2J2, OR2H1, OR5U1, OR10C1, RFP, RFN39 and TRIM39 SNPs were significantly associated with variations in IgM levels (p< 0.001). Manhattan plots showing the association signals for each Ig class and subclass are given in Supplementary Fig. 2 . There was no significant association between serum IgA levels and any of the tested SNPs.
Association between antibody levels and principal components
In order to reduce data dimensionality, we performed principal component analysis (PCA). Immune responses were categorized into two groups. The first group consisted of vaccine specific antibody responses (10 variables) and the second group included Ig levels (7 variables). A number of significant associations were identified between individual principal components and genotypes (Supplementary Table 1 ). SNPs that were significant in both linear regression and PCA are marked in Tables 2 and 3. Supplementary material related to this article can be found, in the online version, at http:// dx.doi.org/10.1016/j.vaccine.2013.09.026.
Association between antibody levels and haplotypes
A number of significant associations were identified between inferred haplotypes and vaccine-induced immune responses both in continuous and binary analyses. Table 4 shows haplotype frequencies and significant associations. Variation in median anti-HBsAg levels was significantly associated with ten haplotypes. The first haplotype included 11 SNPs that were mapped to the RPP21 gene. Two of these SNPs (rs3129820 and rs6936217) were also significant in linear regression analysis. Four of the other haplotypes also included SNPs that showed individual associations with immune response to hepatitis B vaccine. These haplotypes consisted of SNPs in the ZBTB12, BF, TNXB, and NOTCH4 genes. Variation in PnPS4 antibody level was associated with the haplotype that contained five SNPs also identified in the linear regression analysis. All these SNPs were mapped to the HLA-DOB gene. The haplotype correlated with variability in PnPS19F level was constructed by SNPs that were mapped to COL11A2, RXRB, SLC39A7, HSD17B8 and RING1 genes. However, only SNPs mapped to COL11A2, HSD17B8 and RING1 genes were individually associated with PnPS19F levels. Both NOTCH4 SNP and haplotype that included this SNP were associated with variation in PnPS23F serotype level. Haplotypes containing SNPs that showed individual associations are displayed in bold in Table 4. Significant associations were also observed between certain haplotypes and serum immunoglobulin levels (Table 4 ). Many SNPs constructing these haplotypes were also identified in the linear regression analysis. Haplotypes consisting of FLJ35429 and BTNL2 SNPs were significantly associated with variation in IgG, IgG1 and IgG4 levels. Variability in serum IgM levels was associated with 15 haplotypes. Only four of them did not include SNPs that were identified in the linear regression analysis.
Regulatory information for significant associations
The 76 unique significant SNPs identified from initial analyses were used as inputs to the SNP Annotation and Proxy Search (SNAP) tool [33] to find additional SNPs in complete linkage disequilibrium (using an r 2 of 1). This led to the identification of an additional 149 perfectly correlated SNPs using data from the International HapMap Project [35] . The total set of 225 SNPs was then used as inputs to the RegulomeDB [34] web resource, which integrates data from the ENCODE projects and other data sources regarding various types of functional assays including DNaseI-seq, ChIP-seq, RNAseq, and eQTL analyses. Coordinates of both significant and correlated SNPs were derived from hg19 to ensure that they match the locations of variants in RegulomeDB. SNPs with RegulomeDB scores between 1 and 3 (inclusive, where scoring refers to available datatypes supporting a functional role for the variant) and related genes are listed in Table 5 .
Discussion
Consistent with previous studies, the present study demonstrates that MHC region variants significantly contribute to vaccine-specific antibody responses in a relatively specific and predictable manner. The MHC region exhibits high levels of allelic diversity and extensive patterns of LD encompassing multiple genes involved in immunity. The MHC class II molecules were extensively studied in relation to vaccine induced immune responses and their variations were found to be associated with altered antibody production against the presented antigen [36-38]. However, very little is published on vaccine-induced immunogenicity regarding genetic variation in other parts of the MHC region [7] . Since the significant association signals may tag nearby functional SNPs due to high levels of LD within the region, we identified highly correlated SNPs within 500 kb and assessed their regulatory potential. This analysis showed that significant signals from different regions of the MHC are correlated with SNPs that control the expression of a small number of genes involved in antigen processing and presentation.
Previous reports demonstrated that the immune response to hepatitis B vaccine is largely determined by HLA-DR and HLA-DQ alleles [9, 17, 39] . Certain HLA class II alleles were associated with high (DRB1*01, DRB1*11, DRB1*15, DQB1*0501, DPB1*0401) and poor or non-response to HBV (DRB1*03, DRB1*07, DQB1*02, DPB1*1101). In line with these observations, we found HLA-DR and HLA-DQ SNPs to be significantly associated with the variations in median anti-HBsAg antibody levels. HLA-DRA rs3135395, rs3135338, and rs984778 SNPs were in strong LD. Functional annotation of SNPs using RegulomeDB showed that these SNPs regulate the expression level of genes including HLA-DRA, HLA-DQA1, HLA-DRB1, HLA-DRB5 and ERG. Similarly, HLA-DQA1 rs2187668 SNP had a regulatory effect on HLA-DQA1, BTN3A2, HLA-A, HLA-DPB1, HLA-DQB1, HLA-DRB1 and HLA-DRB5 genes. Interestingly, the HLA-DQA1 gene was also regulated by NOTCH4 SNPs (rs3131296 and rs3134942) and two highly correlated TNXB (rs1150752, rs1150753) SNPs. We were not able to find regulatory information for RPP21 rs3129820 and rs6936217 SNPs, but both of them were highly correlated with two SNPs (rs3129822 and rs3094035) that affect the expression of HLA-A, BNTN3A2, HLA-C, HLA-DQA1, HLA-DQB1, HLA-DRB1, HLA-G and HLA-H genes. The role of other genes has not been extensively characterized in the context of vaccine immunity.
SNPs mapped to the HLA-DOB, TAP2, COL11A2, LEMD2, HSD17B8, RING1 and NOTCH4 genes were associated with the variations in immune response to PnPS serotypes. Five SNPs mapping to the HLA-DOB gene were associated with PnPS4 serotype and interestingly, they were correlated with the same SNP (rs2067577) that affects the regulation of HLA-DOB, HLA-DRB5 and TAP-2 genes. HLA-DR plays a central role in the presentation of peptides on the cell surface for T-cell recognition. HLA-DOB is an important modulator in the HLA class II restricted antigen presentation pathway by interaction with the HLA-DM molecule in B-cells. The transporter associated with antigen processing (TAP) gene, a member of the ATP-binding cassette transporter super family, is involved in the processing of endogenous peptides that bind to MHC class I molecules [40] . It has been suggested that TAP polymorphisms may cause differential antigen processing and thereby influence antigen presentation by MHC molecules. TAP2 allelic variants have also been found associated with measles antibody response [41, 42] . Based on their role in the process of the immunogenic peptides, it is plausible that genetic variability within HLA-DOB, HLA-DR and TAP-2 genes may affect the efficiency of antigen presentation and thereby vaccine immunogenicity. Two highly linked NOTCH4 SNPs (rs2071287 and rs2071277) showed significant association with PnPS23F serotype in linear regression analysis. Notably, these two SNPs were also associated with the third principal component of vaccine specific antibody group. The RegulomeDB database showed that the rs2071287 SNP has a regulatory effect on HLA-DQA1 and HLA-DQB1 genes. There are no previous studies reporting association between MHC SNPs and antibody levels to diphtheria. In line with this, we did not find any association between SNPs and diphtheria induced immune responses in our population. This could be related to the nature of the vaccine, as toxoid vaccines tend not to be highly immunogenic.
A large number of SNPs were associated with total serum Ig levels and mapped to BNTL2, RFP, OR2W1, OR2J3, OR2J2, OR5U1, OR10C1, OR2H1, MAS1L, FLJ35429, HLA-F, HLA-G, HCG9, RFN39, TRIM39, HLA-C and HLA-DRA genes. In the association analysis, the variations in median IgM, IgG and IgG1 levels were significantly associated with FLJ35429 and HLA-F linked SNPs. RegulomeDB showed that the FLJ35429 rs1611350 SNP affects the regulation of BTN3A2, HLA-A and ZFP57 genes. The function of the BTN3A2 and ZFP57 genes in immune response is yet unknown. Although no regulatory information exists for the HLA-F SNPs (rs1628578 and rs2517911), both variants were in strong LD with another HLA-F SNP rs1632967, which affects the expression of HLA-G. HLA-A and HLA-G are non-classical class I proteins that play a central role in antigen presentation and immunomodulation [43, 44] . HLA-G and its polymorphic sites have been associated with susceptibility to viral infections and autoimmune diseases [45, 46] . These three SNPs (rs1611350, rs1628578 and rs2517911) were associated with IgG1, IgG and IgM levels suggesting that genetic variability at these loci may play role in the quantitative regulation of other antibody responses and represent plausible candidate genetic modifiers of vaccine immunity.
Two SNPs mapped to the OR2J2 (rs3116830) and RFP (rs3118361) genes were associated with IgM levels and found to be correlated with the same five SNPs (rs3130893, rs3129791, rs3130837, rs3130845 and rs3131073) that affect HLA-A gene expression. The TRIM39 (rs3130380) and RNF39 (rs9261290) SNPs that were associated with IgM levels were also found to influence HLA-A gene regulation. Six IgM-associated SNPs mapped to the HLA-DRA gene and their correlated SNPs were found to be affecting the regulation of HLA-DRB5, HLA-DQB1 and HLA-DQA1 genes. Results from PCA analysis showed that the second principal component of Ig group was associated with SNPs mapped to the RFP, OR2W1, OR2J3 and OR2J2 genes. Some of the SNPs that overlapped with the SNPs identified in the linear regression analysis (except rs381808) were also significant in logistic regression analysis with binary cut-off 15%. This might be explained by the fact that some SNPs were mapped to the same genes or haplotypes or they were physically close to each other to show association as a group.
The majority of the haplotype associations were related to the variations in median antiHBsAg and IgM levels. Although some SNPs within the blocks mapped to genes involved in antigen presentation (HLA-A, HLA-G, HLA-DOB, TAP-2), most mapped to genes with unidentified immune functions (e.g., FLJ35429, C6orf15, RFP, OR5U1). Some of the haplotypes included SNPs that were also identified in the linear regression analysis. This might be due to a strong correlation between SNPs that construct the haplotype. Either high LD between SNPs caused the association to spread across the haplotype or strong association with the haplotypes let individual SNPs to be significant. SNPs identified only in linear regression analysis were possibly not included in any of the haplotypes or haplotypes including these SNPs did not reach statistical significance (p< 0.001). This is also true for the identified haplotypes that did not contain any significant SNPs from the regression analysis. Overall, strong association with certain haplotypes and individual SNPs that construct these haplotypes suggest that genetic variability in this region is strongly correlated with altered immune responses. This is the first study reporting associations between SNPs within the entire MHC and immune response to childhood vaccines and suggests that this region is likely to contain a number of genes that affect vaccine responsiveness. The results were not corrected for multiple comparisons since our analysis was based on the well-defined role of the MHC in immune responses. Instead, we reported all tests that reached a p< 0.001 level of significance and focused on the functional relevance of SNPs associated with vaccine specific responses. Although functional annotation of SNPs was supported by experimental regulatory data, the significance of these findings requires further validation. Replication in independent samples, fine mapping and functional studies may reveal the genetic mechanisms underlying these associations. More importantly, pathways/allelic variants identified through genetic studies may help the development of more uniformly effective next-generation vaccine formulations that could improve vaccine immunogenicity and efficacy. Table 2 Linear regression results for vaccine-specific antibody responses. Table 3 Linear regression results for immunoglobulin levels. Vaccine. Author manuscript; available in PMC 2015 November 10.
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